---
document_datetime: 2025-12-02 05:27:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/nitisinone-mdk.html
document_name: nitisinone-mdk.html
version: success
processing_time: 0.1053225
conversion_datetime: 2025-12-24 17:53:23.755893
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Nitisinone MDK (previously Nitisinone MendeliKABS)

[RSS](/en/individual-human-medicine.xml/66653)

##### Withdrawn

This medicine's authorisation has been withdrawn

nitisinone Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Nitisinone MDK (previously Nitisinone MendeliKABS)](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 March 2023, the European Commission withdrew the marketing authorisation for Nitisinone MDK (nitisinone) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, MendeliKABS Europe Limited, which notified the European Commission of its decision to permanently discontinue the marketing of the product in the EU for commercial reasons.

Nitisinone MDK was granted marketing authorisation in the EU on 24 August 2017 for the treatment of hereditary tyrosinaemia type 1 (HT-1). The marketing authorisation was initially valid for a 5-year period. It was granted unlimited validity in 2022.

Nitisinone MDK is a generic medicine of Orfadin. There are other generic medicinal products of Orfadin authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Nitisinone MDK is updated to indicate that the marketing authorisation is no longer valid.

Nitisinone MDK  (previously Nitisinone MendeliKABS) : EPAR - Summary for the public

Reference Number: EMA/649866/2017

English (EN) (679.23 KB - PDF)

**First published:** 05/10/2017

**Last updated:** 14/06/2023

[View](/en/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-232)

български (BG) (773.87 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/bg/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_bg.pdf)

español (ES) (679.65 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/es/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_es.pdf)

čeština (CS) (756.02 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/cs/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_cs.pdf)

dansk (DA) (678.67 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/da/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_da.pdf)

Deutsch (DE) (681.76 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/de/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_de.pdf)

eesti keel (ET) (677.59 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/et/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_et.pdf)

ελληνικά (EL) (777.9 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/el/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_el.pdf)

français (FR) (680.67 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/fr/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_fr.pdf)

hrvatski (HR) (699.73 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/hr/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_hr.pdf)

italiano (IT) (677.84 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/it/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_it.pdf)

latviešu valoda (LV) (751.65 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/lv/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (704.27 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/lt/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_lt.pdf)

magyar (HU) (747.38 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/hu/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_hu.pdf)

Malti (MT) (755.35 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/mt/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_mt.pdf)

Nederlands (NL) (679.76 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/nl/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_nl.pdf)

polski (PL) (753.36 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/pl/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_pl.pdf)

português (PT) (679.47 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/pt/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_pt.pdf)

română (RO) (703.65 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/ro/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_ro.pdf)

slovenčina (SK) (752.6 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sk/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_sk.pdf)

slovenščina (SL) (743.85 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sl/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_sl.pdf)

Suomi (FI) (679.02 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/fi/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_fi.pdf)

svenska (SV) (678.22 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sv/documents/overview/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-summary-public_sv.pdf)

Nitisinone MDK : EPAR - Risk management plan summary

English (EN) (715.42 KB - PDF)

**First published:** 24/03/2022

**Last updated:** 14/06/2023

[View](/en/documents/rmp-summary/nitisinone-mdk-epar-risk-management-plan-summary_en.pdf)

## Product information

Nitisinone MDK : EPAR - Product Information

English (EN) (890.15 KB - PDF)

**First published:** 05/10/2017

**Last updated:** 14/06/2023

[View](/en/documents/product-information/nitisinone-mdk-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-761)

български (BG) (1.88 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/bg/documents/product-information/nitisinone-mdk-epar-product-information_bg.pdf)

español (ES) (1.06 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/es/documents/product-information/nitisinone-mdk-epar-product-information_es.pdf)

čeština (CS) (1.57 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/cs/documents/product-information/nitisinone-mdk-epar-product-information_cs.pdf)

dansk (DA) (1.06 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/da/documents/product-information/nitisinone-mdk-epar-product-information_da.pdf)

Deutsch (DE) (1.08 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/de/documents/product-information/nitisinone-mdk-epar-product-information_de.pdf)

eesti keel (ET) (1.04 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/et/documents/product-information/nitisinone-mdk-epar-product-information_et.pdf)

ελληνικά (EL) (1.88 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/el/documents/product-information/nitisinone-mdk-epar-product-information_el.pdf)

français (FR) (1.08 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/fr/documents/product-information/nitisinone-mdk-epar-product-information_fr.pdf)

hrvatski (HR) (1.1 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/hr/documents/product-information/nitisinone-mdk-epar-product-information_hr.pdf)

íslenska (IS) (1.06 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/is/documents/product-information/nitisinone-mdk-epar-product-information_is.pdf)

italiano (IT) (1.06 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/it/documents/product-information/nitisinone-mdk-epar-product-information_it.pdf)

latviešu valoda (LV) (1.64 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/lv/documents/product-information/nitisinone-mdk-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.11 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/lt/documents/product-information/nitisinone-mdk-epar-product-information_lt.pdf)

magyar (HU) (1.6 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/hu/documents/product-information/nitisinone-mdk-epar-product-information_hu.pdf)

Malti (MT) (1.71 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/mt/documents/product-information/nitisinone-mdk-epar-product-information_mt.pdf)

Nederlands (NL) (1.03 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/nl/documents/product-information/nitisinone-mdk-epar-product-information_nl.pdf)

norsk (NO) (1.08 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/no/documents/product-information/nitisinone-mdk-epar-product-information_no.pdf)

polski (PL) (1.6 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/pl/documents/product-information/nitisinone-mdk-epar-product-information_pl.pdf)

português (PT) (1.05 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/pt/documents/product-information/nitisinone-mdk-epar-product-information_pt.pdf)

română (RO) (1.16 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/ro/documents/product-information/nitisinone-mdk-epar-product-information_ro.pdf)

slovenčina (SK) (1.6 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sk/documents/product-information/nitisinone-mdk-epar-product-information_sk.pdf)

slovenščina (SL) (1.57 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sl/documents/product-information/nitisinone-mdk-epar-product-information_sl.pdf)

Suomi (FI) (1.04 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/fi/documents/product-information/nitisinone-mdk-epar-product-information_fi.pdf)

svenska (SV) (1.02 MB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sv/documents/product-information/nitisinone-mdk-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** R/0013 15/07/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Nitisinone MDK (previously Nitisinone MendeliKABS) : EPAR - All Authorised presentations

English (EN) (627.25 KB - PDF)

**First published:** 05/10/2017

**Last updated:** 14/06/2023

[View](/en/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-274)

български (BG) (633.44 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/bg/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_bg.pdf)

español (ES) (628.4 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/es/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_es.pdf)

čeština (CS) (651.31 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/cs/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (628.03 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/da/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (628.7 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/de/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (627.19 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/et/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (665.56 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/el/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_el.pdf)

français (FR) (626.95 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/fr/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (644.5 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/hr/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (627.12 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/is/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_is.pdf)

italiano (IT) (627.07 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/it/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (658.65 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/lv/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (646.42 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/lt/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (671.24 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/hu/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (687.4 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/mt/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (627.19 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/nl/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (628.07 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/no/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_no.pdf)

polski (PL) (662.43 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/pl/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_pl.pdf)

português (PT) (627.58 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/pt/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_pt.pdf)

română (RO) (636.43 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/ro/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (660.14 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sk/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (659.53 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sl/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (626.29 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/fi/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (628.13 KB - PDF)

**First published:**

05/10/2017

**Last updated:**

14/06/2023

[View](/sv/documents/all-authorised-presentations/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Nitisinone MDK (previously Nitisinone MendeliKABS) Active substance nitisinone International non-proprietary name (INN) or common name nitisinone Therapeutic area (MeSH) Tyrosinemias Anatomical therapeutic chemical (ATC) code A16AX04

### Pharmacotherapeutic group

Other alimentary tract and metabolism products

### Therapeutic indication

Treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (HT 1) in combination with dietary restriction of tyrosine and phenylalanine.

## Authorisation details

EMA product number EMEA/H/C/004281

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

MendeliKABS Europe Ltd

Unit 3D, North Point House

Opinion adopted 22/06/2017 Marketing authorisation issued 24/08/2017 Revision 6

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Nitisinone MDK (previously Nitisinone MendeliKABS) : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (757 KB - PDF)

**First published:** 05/10/2017

**Last updated:** 14/06/2023

[View](/en/documents/procedural-steps-after/nitisinone-mdk-previously-nitisinone-mendelikabs-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Nitisinone MendeliKABS : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/502860/2017

English (EN) (1.51 MB - PDF)

**First published:** 05/10/2017

**Last updated:** 14/06/2023

[View](/en/documents/assessment-report/nitisinone-mendelikabs-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Nitisinone MendeliKABS

Adopted

Reference Number: EMA/CHMP/368249/2017

English (EN) (645.46 KB - PDF)

**First published:** 23/06/2017

**Last updated:** 14/06/2023

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-nitisinone-mendelikabs_en.pdf)

#### News on Nitisinone MDK (previously Nitisinone MendeliKABS)

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2017](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-june-2017) 23/06/2017

**This page was last updated on** 14/06/2023

## Share this page

[Back to top](#main-content)